Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3448182016 | B-cell lymphoma 2 inhibitor (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT core module |
| 3448183014 | B-cell lymphoma 2 inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 3448184015 | Bcl-2 inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| B-cell lymphoma 2 inhibitor | Is a | Antineoplastic agent | false | Inferred relationship | Existential restriction modifier | ||
| B-cell lymphoma 2 inhibitor | Has disposition | B-cell lymphoma 2 inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| B-cell lymphoma 2 inhibitor | Is a | Substance with effector mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Venetoclax | Is a | True | B-cell lymphoma 2 inhibitor | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR